Your search returned 3 results.

Results
	1.	Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program. MedStar authors: Aroda, Vanita R PMID: 29220533 Year: 2018 Citation: Journal of Clinical Endocrinology & Metabolism. 103(2):486-496, 2018 02 01. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Carrion-Petersen M, Diabetes Prevention Program Outcomes Study Group, Edelstein SL, Ehrmann DA, Goldberg RB, Kim C, Younes N DOI: https://dx.doi.org/10.1210/jc.2017-01829 Add to cart (remove)
	2.	Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors: Aroda, Vanita R PMID: 28833481 Year: 2017 Citation: Diabetic Medicine. 34(12):1747-1755, 2017 Dec. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group DOI: https://dx.doi.org/10.1111/dme.13453 Add to cart (remove)
	3.	A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors: Aroda, Vanita R PMID: 28939018 Year: 2017 Citation: Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE DOI: https://dx.doi.org/10.1016/j.jdiacomp.2017.08.005 Add to cart (remove)

Powered by Koha